GILDER GAGNON HOWE & CO LLC - PROQR THRAPEUTICS N V ownership

PROQR THRAPEUTICS N V's ticker is PRQR and the CUSIP is N71542109. A total of 49 filers reported holding PROQR THRAPEUTICS N V in Q4 2022. The put-call ratio across all filers is 1.72 and the average weighting 0.3%.

Quarter-by-quarter ownership
GILDER GAGNON HOWE & CO LLC ownership history of PROQR THRAPEUTICS N V
ValueSharesWeighting
Q4 2022$358,874
+398.4%
96,993
-0.0%
0.01%
+600.0%
Q3 2022$72,000
-5.3%
97,019
-0.8%
0.00%0.0%
Q2 2022$76,000
-14.6%
97,827
-0.0%
0.00%0.0%
Q1 2022$89,000
-99.2%
97,851
-92.9%
0.00%
-98.4%
Q4 2021$11,047,000
+14.5%
1,379,123
+19.6%
0.06%
+26.0%
Q3 2021$9,650,000
+176.0%
1,152,912
+122.3%
0.05%
+194.1%
Q2 2021$3,496,000518,7330.02%
Other shareholders
PROQR THRAPEUTICS N V shareholders Q4 2022
NameSharesValueWeighting ↓
Privium Fund Management B.V. 5,344,446$18,010,7836.83%
M28 Capital Management LP 1,910,600$7,069,2206.74%
Opaleye Management Inc. 1,460,000$5,402,0001.88%
Ikarian Capital, LLC 422,625$1,563,7130.38%
Monaco Asset Management SAM 165,000$610,5000.18%
AWM Investment Company, Inc. 166,667$616,6680.09%
FRANKLIN STREET ADVISORS INC /NC 150,000$5550.05%
Atom Investors LP 18,522$68,5310.03%
ADAGE CAPITAL PARTNERS GP, L.L.C. 3,625,467$13,414,2280.03%
GSA CAPITAL PARTNERS LLP 21,514$800.01%
View complete list of PROQR THRAPEUTICS N V shareholders